Fluxid Related Published Studies
Well-designed clinical trials related to Fluxid (Famotidine)
Esomeprazole Compared With Famotidine in the Prevention of Upper Gastrointestinal Bleeding in Patients With Acute Coronary Syndrome or Myocardial Infarction. [2011.11.22]
Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers. [2011.07]
Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study. [2011.03]
Efficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs. [2011.01]
A double-blind, controlled study comparing lafutidine with placebo and famotidine in Japanese patients with mild reflux esophagitis. [2010.12]
Efficacy of omeprazole versus high-dose famotidine for prevention of exercise-induced gastritis in racing Alaskan sled dogs. [2010.03]
Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. [2010.01]
A double-blind, controlled study comparing lafutidine with placebo and famotidine
in Japanese patients with mild reflux esophagitis. [2010]
Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. [2009.07.11]
Early effects of intravenous administrations of lansoprazole and famotidine on intragastric pH. [2009.03]
Can famotidine and omeprazole be combined on a once-daily basis? [2007.06]
Which has superior acid-suppressive effect, 10 mg omeprazole once daily or 20 mg famotidine twice daily? Effects of single or repeated administration in Japanese Helicobacter pylori-negative CYP2C19 extensive metabolizers. [2007.02]
Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P450 2C19 genotype status. [2006.11]
Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection. [2006.10]
Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial. [2006.09.01]
Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective? [2006.04]
Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine. [2006.01]
Effect of pre-operative short course famotidine on tumor infiltrating lymphocytes in colorectal cancer: a double blind, placebo controlled, prospective randomized study. [2005.12]
Effect of preoperative short course famotidine on TILs and survival in breast cancer. [2005.10]
Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status. [2005.07.01]
Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine. [2005.07]
A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration. [2005.06]
Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine. [2005.06]
New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. [2005.06]
Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia. [2005.06]
Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies. [2005.06]
Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia. [2005.06]
Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease. [2005.06]
Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease. [2005.06]
Concomitant dosing of famotidine with a triple therapy increases the cure rates of Helicobacter pylori infections in patients with the homozygous extensive metabolizer genotype of CYP2C19. [2005.02.15]
Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis. [2005.02]
Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial. [2005]
Pharmacokinetics of famotidine in infants. [2005]
Well-designed clinical trials possibly related to Fluxid (Famotidine)
A randomized clinical trial of histamine 2 receptor antagonism in
treatment-resistant schizophrenia. [2013]
Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy. [2010.11.14]
[Efficacy evaluation of lafutidine for mild reflux esophagitis in Japanese patients] [2010.04]
Rebamipide may be comparable to H2 receptor antagonist in healing iatrogenic gastric ulcers created by endoscopic mucosal resection: a prospective randomized pilot study. [2010.04]
[Efficacy evaluation of lafutidine for mild reflux esophagitis in Japanese patients]. [2010.04]
Stress ulcer, gastritis, and gastrointestinal bleeding prophylaxis in critically ill pediatric patients: a systematic review. [2010.01]
[Efficacy evaluation of lafutidine for mild reflux esophagitis in Japanese
patients]. [Article in Japanese] [2010]
Effectiveness of medications used to attenuate antipsychotic-related weight gain
and metabolic abnormalities: a systematic review and meta-analysis. [2010]
Novel and emerging treatments for autism spectrum disorders: a systematic review. [2009.10]
Stress ulcer, gastritis, and gastrointestinal bleeding prophylaxis in critically ill pediatric patients: A systematic review* [2009.09.15]
Phase I study of the effect of gastric acid pH modulators on the bioavailability of oral dasatinib in healthy subjects. [2009.06]
Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria. [2009]
Triple antimicrobial therapy and acid suppression in dogs with chronic vomiting and gastric Helicobacter spp. [2007.11]
Use of histamine2-antagonists for the treatment of verruca vulgaris. [2007.07]
Use of Histamine2-Antagonists for the Treatment of Verruca Vulgaris (July/August). [2007.05.29]
Lafutidine can improve the quality of gastric ulcer healing in humans: a randomized, controlled, multicenter trial. [2006.12]
Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies. [2006.10.03]
Oral sodium citrate increases nausea amongst elective Cesarean delivery patients. [2006.08]
Analgesic and antacid properties of i.m. tramadol given before Caesarean section under general anaesthesia. [2005.12]
High-performance liquid chromatographic determination of lamivudine in human serum using liquid-liquid extraction; application to pharmacokinetic studies. [2005.09.05]
One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection. [2005.09]
[Effects of oral clonidine premedication on the heart rate response to intravenous atropine during propofol anesthesia] [2005.09]
Management of symptoms in step-down therapy of gastroesophageal reflux disease. [2005.09]
Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin. [2005.03.21]
Other research related to Fluxid (Famotidine)
Famotidine as a radioprotector for rectal mucosa in prostate cancer patients
treated with radiotherapy: phase I/II randomized placebo-controlled trial. [2014]
Platelet inhibitory effect of clopidogrel in patients treated with omeprazole,
pantoprazole, and famotidine: a prospective, randomized, crossover study. [2013]
Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: A double-blind, randomized trial. [2011.11]
Pulse interleukin-2 with famotidine induces CD56+ lymphocytes in the peripheral blood of patients with metastatic melanoma or kidney cancer. [2011.02]
Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists. [2011.02]
Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: a
double-blind, randomized trial. [2011]
Comparison of the efficacy of irsogladine maleate and famotidine for the healing
of gastric ulcers after Helicobacter pylori eradication therapy: a randomized,
controlled, prospective study. [2011]
Preventive effects of lansoprazole and famotidine on gastric mucosal injury
induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers. [2011]
Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients. [2010.10]
Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine. [2010.09.15]
Preventive Effects of Lansoprazole and Famotidine on Gastric Mucosal Injury Induced by Low-Dose Aspirin in Helicobacter pylori-Negative Healthy Volunteers. [2010.07.27]
A double-blind, controlled study comparing lafutidine with placebo and famotidine in Japanese patients with mild reflux esophagitis. [2010.07.15]
Preparation and evaluation of famotidine polymorphs. [2010.06.01]
Pulse infusion interleukin-2 with famotidine and cyclophosphamide has activity in previously treated metastatic melanoma. [2010.04]
Floating controlled drug delivery system of famotidine loaded hollow microspheres (microballoons) in the stomach. [2010.01.01]
Floating controlled drug delivery system of famotidine loaded hollow microspheres (microballoons) in the stomach. [2010.01]
A case of famotidine-induced anaphylaxis. [2010]
Efficacy of omeprazole versus high-dose famotidine for prevention of
exercise-induced gastritis in racing Alaskan sled dogs. [2010]
Famotidine is inferior to pantoprazole in preventing recurrence of
aspirin-related peptic ulcers or erosions. [2010]
Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. [2009.10.15]
A fixed dose combination of ibuprofen and famotidine. [2009.09]
Are proton pump inhibitors really superior to famotidine in Japanese ulcer patients? [2009.07]
High-dose intensity pulse interleukin-2 with famotidine in metastatic kidney cancer. [2009.04]
Famotidine orally disintegrating tablets: bitterness comparison of original and generic products. [2009.04]
Effects of combination treatment with famotidine and methylmethionine sulfonium chloride on the mucus barrier of rat gastric mucosa. [2009.03]
Activity of continuous infusion + pulse interleukin-2 with famotidine in metastatic melanoma. [2009.02]
Development of modified dosage form for enhancement of dissolution rate through amalgamation of solid dispersion and cube sugar or sintering technology using famotidine as a model drug. [2009.01]
Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis. [2009]
Intravenous famotidine does not always change core temperature during general anesthesia. [2009]
Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study. [2009]
Effects of mepyramine and famotidine on the physostigmine-induced antinociception in the formalin test in rats. [2008.11.15]
Optimization studies on floating multiparticulate gastroretentive drug delivery system of famotidine. [2008.11]
High-dose intensity pulse interleukin-2 with famotidine has activity in metastatic melanoma. [2008.10]
[Efficacy and safety of famotidine for the treatment of stress ulcers in neonates] [2008.10]
Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. [2008.08]
Prevention of Indomethacin-Induced Gastric Mucosal Injury in Helicobacter pylori-Negative Healthy Volunteers: A Comparison Study Rebamipide vs Famotidine. [2008.07]
Famotidine polymorphic transformation in the grinding process significantly depends on environmental humidity or water content. [2008.06.05]
The effect of famotidine, esomeprazole, and ezetimibe on levothyroxine absorption. [2008.05]
Formulation design of taste-masked particles, including famotidine, for an oral fast-disintegrating dosage form. [2008.04]
Famotidine versus pantoprazole for preventing bleeding in the upper gastrointestinal tract of critically ill patients receiving mechanical ventilation. [2008.03]
Risk of hemolytic anemia with intravenous administration of famotidine to hospitalized cats. [2008.03]
Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer. [2008.02]
A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease. [2008]
Preparation and evaluation of taste masked famotidine formulation using drug/beta-cyclodextrin/polymer ternary complexation approach. [2008]
|